Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
4,343,993
-
Shares change
-
+319,314
-
Total reported value, excl. options
-
$56,286,719
-
Value change
-
+$4,058,859
-
Number of buys
-
40
-
Number of sells
-
-11
-
Price
-
$12.95
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q3 2021
69 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q3 2021.
XBiotech Inc. - Common Shares, no par value (XBIT) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,343,993 shares
of 33,289,095 outstanding shares and own 13.05% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1,223,654 shares), VANGUARD GROUP INC (884,982 shares), STATE STREET CORP (435,590 shares), GEODE CAPITAL MANAGEMENT, LLC (306,118 shares), NORTHERN TRUST CORP (251,251 shares), WELLS FARGO & COMPANY/MN (147,447 shares), CREDIT SUISSE AG/ (135,252 shares), Nuveen Asset Management, LLC (70,416 shares), Bank of New York Mellon Corp (58,906 shares), and AQR CAPITAL MANAGEMENT LLC (57,445 shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.